KSL.com Salt Lake City — News
01/11/2026 13:35

Preclinical research at BYU may lead to development of low-cost immunotherapy

Researchers at BYU are investigating a new immunotechnology called MOTO-CAR, which can genetically engineer immune cells that penetrate solid tumors and attacks the tumor cells.
📄 Contenido indexado automáticamente. No es de autoría de altabusqueda.com; los derechos pertenecen a su fuente: KSL.com Salt Lake City — News.
Ver nota original ↗
🤖 Profundizá esta noticia con OIMA (IA)

¿Querés un resumen rápido de esta noticia, hecho por nuestra IA?

Respuestas de OIMA · IA, sobre esta noticia · Abrir OIMA Chat ↗
💬 0

Comentarios

También te puede interesar

509 Utahns told us their hopes and concerns for Great Salt Lake. Do you feel the same?
KSL.com Salt Lake City — News
A survey of 509 Utahns found widespread concern about the Great Salt Lake's declining water levels, toxic dus…
New Moab excavation site could be oldest Cretaceous dinosaur bonebed in North America
KSL.com Salt Lake City — News
Scientists interested in learning more about the mass extinction of dinosaurs are ecstatic over a new excavat…
Box Office: 'You Can See Everything,' 'Clayface' lead sleepy Halloween weekend
KSL.com Salt Lake City — News
The North American box office faced a slump this weekend as Halloween festivities drew people away from theat…
Utah moves into top 5 as BYU inches up in latest AP Top 25 rankings
KSL.com Salt Lake City — News
With only one month left in the regular season, both BYU and Utah have all their season goals still within re…
Russia's security service detains a teenager planning a 'terror attack' after a US tip-off
KSL.com Salt Lake City — News
A suspect allegedly planning a terror attack on a major Moscow museum was arrested by Russian authorities aft…
How a champion of the 'Utah Way' became a casualty of America's AI debate
KSL.com Salt Lake City — News
Stuart Adams helped Utah bridge America's divides. Data centers proved a different story.